Key facts
- This page summarizes Citius Pharmaceuticals, Inc.'s Form 4 filing for CITIUS ONCOLOGY, INC. (CTOR).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 14 Aug 2024, 18:25.
Citius Pharmaceuticals, Inc. - 12 Aug 2024 Form 4 Insider Report for CITIUS ONCOLOGY, INC. (CTOR)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- CTOR
- Reported as of
- 12 Aug 2024
- Net transaction value
- $0
- Reporting owner signature
- /s/ Lorna A. Knick, by Power of Attorney
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Citius Pharmaceuticals, Inc. filed Form 4 for CITIUS ONCOLOGY, INC. (CTOR) on 14 Aug 2024.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CTOR
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 65,627,262
- Date
- 12 Aug 2024
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
SEC remarks
Exhibit 24.1: Power of Attorney